Lipoprotein Outer Surface A Vaccine Articles
GSK pulls LYMErix on lackluster sales
4 March 2002
FDA panel reviews LYMErix safety
1 February 2001
ImmuLyme dropped in favor of new vaccine
17 February 2000
Busy year for NCEs as major new compound classes launched
6 January 2000
SmithKline Beecham files for US approval of new quinolone
16 December 1999
SB's LYMErix vaccine effective in asymptomatic patients
25 November 1999
MedImmune/PMC plan improved Lyme vaccine
7 July 1999
SB launches LYMErix in Canada
29 April 1999
Currency impact lifts SmithKline Beecham
20 April 1999
Stock Commentary Europe
4 February 1999
SmithKline Beecham launch DTC ad for LYMErix
21 January 1999
SB's Lyme disease vaccine approved
23 December 1998
SB's LymeRix Vaccine Regimen Simplified
13 October 1998
Currency And Flu Factors Hold Back SB Results
22 July 1998
FDA Panel Backs SB's Lyme Disease Vaccine
28 May 1998
SB Defends Independence On Strong R&D Grounds
23 April 1998
Showing 1-18 of 18 articles
- 1
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
